Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for transthiolation intermediates in the ubiquitin pathway. | Nature | 2024 | 39143218 | PubTator, text mining | PubMed |
| UBE2M forms a positive feedback loop with estrogen receptor to drive breast cancer progression and drug resistance. | Cell Death Dis | 2024 | 39138151 | PubTator, text mining | PubMed |
| Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome. | Curr Opin Neurobiol | 2024 | 39126903 | PubTator, text mining | PubMed |
| A case of an Angelman-syndrome caused by an intragenic duplication of UBE3A uncovered by adaptive nanopore sequencing. | Clin Epigenetics | 2024 | 39095842 | PubTator, text mining | PubMed |
| Integration of CTCF loops, methylome, and transcriptome in differentiating LUHMES as a model for imprinting dynamics of the 15q11-q13 locus in human neurons. | Hum Mol Genet | 2024 | 39045627 | PubTator, text mining | PubMed |
| Sex-biasing influence of autism-associated Ube3a gene overdosage at connectomic, behavioral, and transcriptomic levels. | Sci Adv | 2024 | 38996019 | PubTator, text mining | PubMed |
| Ube3a unsilencer for the potential treatment of Angelman syndrome. | Nat Commun | 2024 | 38977672 | PubTator, text mining | PubMed |
| Interlinked destinies: How ubiquitin-proteasome and autophagy systems underpin neurocognitive outcomes. | Exp Neurol | 2024 | 38901755 | PubTator, text mining | PubMed |
| Developmental milestones and daily living skills in individuals with Angelman syndrome. | J Neurodev Disord | 2024 | 38879552 | PubTator, text mining | PubMed |
| Regional and cellular organization of the autism-associated protein UBE3A/E6AP and its antisense transcript in the brain of the developing rhesus monkey. | Front Neuroanat | 2024 | 38873093 | PubTator, text mining | PubMed |
| All-trans retinoic acid downregulates HBx levels via E6-associated protein-mediated proteasomal degradation to suppress hepatitis B virus replication. | PLoS One | 2024 | 38861553 | PubTator, text mining | PubMed |
| Generation of three iPSC lines with inducible systems to be used in Angelman syndrome research. | Stem Cell Res | 2024 | 38843694 | PubTator, text mining | PubMed |
| Structural insights into the functional mechanism of the ubiquitin ligase E6AP. | Nat Commun | 2024 | 38670961 | PubTator, text mining | PubMed |
| Expanding deep phenotypic spectrum associated with atypical pathogenic structural variations overlapping 15q11-q13 imprinting region. | Brain Behav | 2024 | 38616334 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase ITCH negatively regulates intercellular communication via gap junctions by targeting connexin43 for lysosomal degradation. | Cell Mol Life Sci | 2024 | 38597989 | PubTator, text mining | PubMed |
| Sleep disturbance in Angelman syndrome patients. | Orphanet J Rare Dis | 2024 | 38580983 | PubTator, text mining | PubMed |
| Cobalamins Function as Allosteric Activators of an Angelman Syndrome-Associated UBE3A/E6AP Variant. | Chembiochem | 2024 | 38573110 | PubTator, text mining | PubMed |
| Impact of Deletion on Angelman Syndrome Phenotype Variability: Phenotype-Genotype Correlation in 97 Patients with Motor Developmental Delay. | J Pediatr Genet | 2024 | 38567176 | PubTator, text mining | PubMed |
| Discovery and characterization of noncanonical E2-conjugating enzymes. | Sci Adv | 2024 | 38536929 | PubTator, text mining | PubMed |
| Undiagnosed rare disease clinic identifies a novel UBE3A variant in two sisters with Angelman syndrome: The end of a diagnostic odyssey. | Congenit Anom (Kyoto) | 2024 | 38520260 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=10